Literature DB >> 8966843

Enhanced gene expression of transforming growth factor-alpha and c-met in rat urinary bladder cancer.

M Inui1, N Nishi, A Yasumoto, I Takenaka, H Miyanaka, K Matsumoto, T Nakamura, F Wada.   

Abstract

To investigate the roles of growth factors in bladder cancer, changes in the expression of messenger RNAs (mRNAs) for several growth factors and their receptors were examined during rat bladder carcinogenesis induced with N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN). Northern blot analysis showed that the contents of mRNAs for transforming growth factor-alpha (TGF-alpha) and c-met/hepatocyte growth factor (HGF) receptor increased with BBN treatment. Epidermal growth factor (EGF) receptor mRNA was hardly affected by the treatment; while mRNA for fibroblast growth factor (FGF) receptor 1 and transforming growth factor-beta (TGF-beta) type II receptor decreased with BBN treatment. A rat bladder tumor cell line, NBT-II, expressed both TGF-alpha and c-met mRNAs, and HGF showed apparent scattering and growth-stimulating effects on the cells. These results indicate the possibility that TGF-alpha produced by a bladder cancer, in addition to urinary EGF, plays a role in the development of bladder cancer, and that enhanced cell motility due to activation of the c-met/HGF receptor participates in the invasion and metastasis of the cancer cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8966843     DOI: 10.1007/bf00296735

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  41 in total

Review 1.  Growth factors and bladder cancer: clinical implications of the interactions between growth factors and their urothelial receptors.

Authors:  E M Messing
Journal:  Semin Surg Oncol       Date:  1992 Sep-Oct

2.  Localization of FGF receptor mRNA in the adult rat central nervous system by in situ hybridization.

Authors:  A Wanaka; E M Johnson; J Milbrandt
Journal:  Neuron       Date:  1990-09       Impact factor: 17.173

3.  Expression of epidermal growth factor receptor proto-oncogene mRNA in regenerating rat liver.

Authors:  A C Johnson; S H Garfield; G T Merlino; I Pastan
Journal:  Biochem Biophys Res Commun       Date:  1988-01-15       Impact factor: 3.575

4.  Identification of epidermal growth factor as a component of the rat urinary bladder tumor-enhancing urinary fractions.

Authors:  Y Yura; O Hayashi; M Kelly; R Oyasu
Journal:  Cancer Res       Date:  1989-03-15       Impact factor: 12.701

5.  Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients.

Authors:  M Nguyen; H Watanabe; A E Budson; J P Richie; J Folkman
Journal:  J Natl Cancer Inst       Date:  1993-02-03       Impact factor: 13.506

6.  Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins.

Authors:  J Scott; M Urdea; M Quiroga; R Sanchez-Pescador; N Fong; M Selby; W J Rutter; G I Bell
Journal:  Science       Date:  1983-07-15       Impact factor: 47.728

7.  Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth.

Authors:  P W Finch; J S Rubin; T Miki; D Ron; S A Aaronson
Journal:  Science       Date:  1989-08-18       Impact factor: 47.728

8.  Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues.

Authors:  K Tashiro; M Hagiya; T Nishizawa; T Seki; M Shimonishi; S Shimizu; T Nakamura
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

9.  Chemiluminescent nucleic acid detection with digoxigenin-labeled probes: a model system with probes for angiotensin converting enzyme which detect less than one attomole of target DNA.

Authors:  J J Lanzillo
Journal:  Anal Biochem       Date:  1991-04       Impact factor: 3.365

10.  Production of transforming growth factor-alpha in human tumour cell lines.

Authors:  K Imanishi; K Yamaguchi; M Suzuki; S Honda; N Yanaihara; K Abe
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

View more
  7 in total

1.  Characterization of HGF/Met Signaling in Cell Lines Derived From Urothelial Carcinoma of the Bladder.

Authors:  Young H Lee; Andrea B Apolo; Piyush K Agarwal; Donald P Bottaro
Journal:  Cancers (Basel)       Date:  2014-11-25       Impact factor: 6.639

2.  Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladder.

Authors:  Brian K McNeil; Maximiliano Sorbellini; Robert L Grubb; Andrea Apolo; Fabiola Cecchi; Gagani Athauda; Benjamin Cohen; Alessio Giubellino; Haley Simpson; Piyush K Agarwal; Jonathan Coleman; Robert H Getzenberg; George J Netto; Joanna Shih; W Marston Linehan; Peter A Pinto; Donald P Bottaro
Journal:  J Transl Med       Date:  2014-10-21       Impact factor: 5.531

Review 3.  c-Met expression and activity in urogenital cancers - novel aspects of signal transduction and medical implications.

Authors:  Ralf Hass; Susanne Jennek; Yuanyuan Yang; Karlheinz Friedrich
Journal:  Cell Commun Signal       Date:  2017-02-17       Impact factor: 5.712

4.  Allelic imbalances on chromosome 20 in human transitional cell carcinoma.

Authors:  S Higashi; T Habuchi; T Takahashi; T Kamoto; Y Kakehi; O Ogawa; H Hiai
Journal:  Jpn J Cancer Res       Date:  2000-05

Review 5.  c-Met: A Promising Therapeutic Target in Bladder Cancer.

Authors:  Yanfei Feng; Zitong Yang; Xin Xu
Journal:  Cancer Manag Res       Date:  2022-08-08       Impact factor: 3.602

Review 6.  Can EGCG Alleviate Symptoms of Down Syndrome by Altering Proteolytic Activity?

Authors:  Marzena Wyganowska-Świątkowska; Maja Matthews-Kozanecka; Teresa Matthews-Brzozowska; Ewa Skrzypczak-Jankun; Jerzy Jankun
Journal:  Int J Mol Sci       Date:  2018-01-15       Impact factor: 5.923

7.  Isolation and characterization of invasive and noninvasive variants of a rat bladder tumor cell line.

Authors:  N Nishi; M Inui; Y Kishi; H Miyanaka; F Wada
Journal:  Jpn J Cancer Res       Date:  1997-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.